CMPI

Checkmate Pharmaceuticals, Inc. Common Stock
CMPI

Overview Fund Activity
Delisted

CMPI was delisted on the 27th of May, 2022.

Back to rankings

37 hedge funds and large institutions have $186M invested in Checkmate Pharmaceuticals, Inc. Common Stock in 2020 Q3 according to their latest regulatory filings, with 37 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
37
Holders Change
+37
Holders Change %
–
% of All Funds
0.75%
Holding in Top 10
4
Holding in Top 10 Change
+4
Holding in Top 10 Change %
%
% of All Funds
0.08%
New
37
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
VP
1
venBio Partners
California
$42.3M
2
SI
2
Sofinnova Investments
California
$41.5M
3
NHAS
3
Novo Holdings A/S
Denmark
$25M
4
MVM
4
Medicxi Ventures Management
Jersey
$17.3M
5
OFM
5
Omega Fund Management
Massachusetts
$15.4M

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Shares
Change %
Bank of America
26
Bank of America
North Carolina
$39K +$39K +3,370 New
AIG
27
American International Group
New York
$35K +$35K +3,019 New
JPMorgan Chase & Co
28
JPMorgan Chase & Co
New York
$20K +$20K +1,882 New
Wells Fargo
29
Wells Fargo
California
$16K +$16K +1,404 New
SO
30
STRS Ohio
Ohio
$14K +$14K +1,300 New
Morgan Stanley
31
Morgan Stanley
New York
$9K +$9K +750 New
UBS Group
32
UBS Group
Switzerland
$7K +$7K +648 New
Legal & General Group
33
Legal & General Group
United Kingdom
$6K +$6K +521 New
AIP
34
Ameritas Investment Partners
Nebraska
$5K +$5K +430 New
Bank of Montreal
35
Bank of Montreal
Ontario, Canada
$3K +$3K +235 New
Citigroup
36
Citigroup
New York
$3K +$3K +242 New
Millennium Management
37
Millennium Management
New York
$1.26K +$1.26K +109,069 New
1
2